Story
Research Alliance Corporation IV Prices $75 Million IPO on Nasdaq
Research Alliance Corporation IV, a special purpose acquisition company (SPAC), has priced its initial public offering of 7.5 million Class A ordinary shares at $10.00 per share, raising gross proceeds of $75 million. The company's shares are now listed on the Nasdaq Capital Market under the ticker symbol RACD.
Offering Details
According to a company press release on July 13, 2026, the offering is expected to close on July 14, 2026, subject to customary closing conditions. The U.S. Securities and Exchange Commission (SEC) had declared the related registration statement effective on July 10, 2026.
Leerink Partners served as the sole bookrunning manager for the IPO. The offering attracted a wide range of institutional investors, including Adage Capital Partners LP, Janus Henderson Investors, and Perceptive Advisors, among others.
AdCompany Strategy
As a blank-check company, Research Alliance Corporation IV was formed for the purpose of effecting a merger, asset acquisition, or other similar business combination. The company, sponsored by an affiliate of RA Capital Management, L.P., stated that it intends to focus its search for a target company within the healthcare or healthcare-related industries.
The SPAC is led by Chief Executive Officer Matthew Hammond, PhD, MBA, and Chief Business Officer/Chief Operating Officer Henry Stusnick. The successful IPO provides the company with capital to pursue a deal, offering a potential path for a private healthcare company to enter the public markets.